October 20, 2017

BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. SANDOZ, INC.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 20, 2017

    Boehringer Sues Drugmakers To Block Generic Gilotrif Plans

    German drugmaker Boehringer Ingelheim Pharmaceuticals Inc. filed a pair of patent infringement suits Friday in New Jersey federal court over bids by Sandoz Inc. and Sun Pharmaceutical Industries to market generic versions of its cancer therapy drug.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!